Shi (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
https://doi.org10.1001/jamacardio.2020.0950
https://www.ncbi.nlm.nih.gov/pubmed/32211816
Comorbidities
Cancer (Present vs. Not present)
COVID-19 (death)
Hazard ratio: 1.750 (0.430-7.160) Adjusted model

China

Retrospective cohort study

Medical records

416

To explore the association between cardiac injury and mortality in patients with COVID-19. This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; the final date of follow-up was February 15, 2020.

Female - the median age was 64 years (range, 21-95 years), and 211 (50.7%) were female.

Total

0 Day


COVID-19 (death)

57

Death


Comorbidities

Cancer

(at symptome onset)

Not present

Present


Hazard ratio

1.750 (0.430-7.160)

No

No

Yes

Age, cardiovascular disease, cerebrovascular diseases, diabetes, COPD, Renal failure, Cancer, ARDS, Cardiac injury, Creatinine ?1.50 mg/dL, N-terminal pro-B-type natriuretic peptide ?900 pg/mL


none

Good

Yes